Aisling Byrne

B.S. Biochemistry (Toxicology Concentration), Rutgers University
Advisor: rotation sutdent
Email: Aisling.Byrne@stonybrook.edu

Presentations

Lin, H.-C., Byrne, A., Raj, E., Rabson, A. B. (2024). Effects of Histone Deacetylase Inhibitors on Ewing Sarcoma Cells [Poster Presentation]. 12^th Annual Department of Pediatrics Research Day, Robert Wood Johnson Medical School, New Brunswick, N.J..

Lin, H.-C., Byrne, A., Raj, E., Rabson, A. B. (2024) Effects of Histone Deacetylase Inhibitors on Ewing Sarcoma Cells [Poster Presentation].  Annual Retreat of Cancer Research in New Jersey, Cancer Institute of New Jersey, New Brunswick, N.J.

Lin, H.-C., King, J., Byrne, A., Walker, S., Li, M.-L., Brewer, G., Rabson, A. B. (2024). Role of RNA binding proteins in Human T Cell Leukemia Virus Type1 RNA stability and gene expression in latently infected CD4 T Cells [Poster Presentation]. International Conference on Human Retrovirology: HTLV and related viruses, Imperial College London and Royal College of Physicians, London, England.

Research Interests

As an undergraduate at Rutgers University, Aisling was a member of a lab researching both Ewing Sarcoma and Human T-Cell Leukemia Virus Type-1 (HTLV-1). The Ewing Sarcoma project questioned the impact of HDAC inhibitors on the histone modifications and gene expression of the pediatric cancer cells, specifically looking for an attenuation of the cell’s malignant phenotype. Meanwhile, the HTLV-1 project focused on the role of RNA binding proteins on the RNA stability and gene expression of CD4+ T-cells which were latently infected with HTLV-1. Aisling continues to have an interest in the overlap between virology and the immune system.

Honors and Awards